RxDoctor Payments Data

Darcy Cook

Family · Emmett, IDNPI 1629699251

Payments from drug & device makers

$2,428in general payments, 2019–2025

Across 121 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$545
  • AstraZeneca$332
  • Otsuka America Pharmaceutical, Inc.$236
  • Antares Pharma, Inc.$151
  • Novartis$134
  • Novo Nordisk$98
  • plus $932 from 26 others

What the payments were for

  • Food & beverage$2,428100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,428 in reported general payments places this provider in the 85th percentile of 809 family providers in Idaho.

See all family providers in Idaho

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide15$14,067
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,066
Albuterol Sulfate HfaAlbuterol Sulfate85$1,792
Torsemide30$786
Levothyroxine Sodium72$748
Cefdinir22$558
Fluticasone Propionate52$550
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav56$494
Potassium Chloride44$491
Gabapentin29$470
Tamsulosin Hcl34$454
Methylprednisolone75$451
Mirtazapine21$378
Famotidine31$366
Ofloxacin14$355

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$98$14,06715 claims
GSKTrelegy Ellipta$54$8,06613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 809 family providers in Idaho.

Other family in Emmett

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →